CALL/SANOFI/130/0.1/20.09.24 Stock

Warrant

DE000GG1FYU0

Market Closed - BOERSE MUENCHEN 14:27:05 2024-06-14 EDT
0.004 EUR +33.33% Intraday chart for CALL/SANOFI/130/0.1/20.09.24
Current month+300.00%
1 month+33.33%
Date Price Change
24-06-14 0.004 +33.33%
24-06-13 0.003 0.00%
24-06-12 0.003 +200.00%
24-06-11 0.001 0.00%
24-06-10 0.001 -50.00%

Real-time BOERSE MUENCHEN

Last update June 14, 2024 at 02:27 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying SANOFI
Issuer Goldman Sachs
WKN GG1FYU
ISINDE000GG1FYU0
Date issued 2023-12-20
Strike 130
Maturity 2024-09-20 (97 Days)
Parity 10 : 1
Emission price 0.01
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.028
Lowest since issue 0.001
Delta0.08x
Omega 9.261
Premium51.3x
Gearing112.25x
Moneyness 0.6648
Difference Strike 43.57
Difference Strike %+33.52%
Spread 0.146
Spread %97.33%
Theoretical value 0.0790
Implied Volatility 50.90 %
Total Loss Probability 94.98 %
Intrinsic value 0.000000
Present value 0.0790
Break even 130.79 €
Theta-0.01x
Vega0.01x
Rho0x

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
86.43 EUR
Average target price
108.2 EUR
Spread / Average Target
+25.18%
Consensus